About the Cardiometabolic Imaging laboratory
The Baker Cardiometabolic Imaging lab focuses on better understanding the mechanisms of heart disease in patients with cardiometabolic conditions through application of cardiovascular magnetic resonance imaging (CMR) imaging and cardiac magnetic resonance spectroscopy (MRS) techniques, and the modification of cardiovascular disease risk by testing novel treatment strategies with randomised clinical trials while monitoring the heart’s response to treatment using CMR imaging and MRS biomarkers.
As well as targeting cardiovascular disease in early disease phenotypes such as adults with isolated type 2 diabetes or obesity without cardiovascular complications, we also investigate the combined impact of diabetes and common cardiovascular conditions such as valvular heart disease, particularly aortic stenosis and inherited cardiomyopathies, in adults who have comorbid diabetes.
Our research focuses on three categories:
- Technical development work to improve advanced CMR imaging and MR Spectroscopy techniques.
- Testing novel treatment strategies with randomised clinical trials by monitoring the heart’s response to treatment using CMR imaging and MR Spectroscopy biomarkers to tackle cardiovascular disease in patients with T2D.
- Improving maternal cardiometabolic health.